Brian P. Mckeon - Feb 14, 2025 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
EVP, CFO and Treasurer
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Brian P. McKeon
Stock symbol
IDXX
Transactions as of
Feb 14, 2025
Transactions value $
-$252,938
Form type
4
Date filed
2/18/2025, 09:44 PM
Previous filing
Aug 7, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $0 +252 +0.81% $0.00 31.2K Feb 14, 2025 Direct F1
transaction IDXX Common Stock Options Exercise $0 +303 +0.97% $0.00 31.5K Feb 14, 2025 Direct
transaction IDXX Common Stock Options Exercise $0 +308 +0.98% $0.00 31.8K Feb 14, 2025 Direct
transaction IDXX Common Stock Options Exercise $0 +299 +0.94% $0.00 32.1K Feb 14, 2025 Direct
transaction IDXX Common Stock Tax liability -$253K -569 -1.77% $444.53 31.5K Feb 14, 2025 Direct
holding IDXX Common Stock 18.1K Feb 14, 2025 by Estony McKeon Family, LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Restricted Stock Unit Options Exercise $0 -252 -100% $0.00 0 Feb 14, 2025 Common Stock 252 Direct F2
transaction IDXX Restricted Stock Unit Options Exercise $0 -303 -50% $0.00 303 Feb 14, 2025 Common Stock 303 Direct F3
transaction IDXX Restricted Stock Unit Options Exercise $0 -308 -33.37% $0.00 615 Feb 14, 2025 Common Stock 308 Direct F4
transaction IDXX Restricted Stock Unit Options Exercise $0 -299 -25.06% $0.00 894 Feb 14, 2025 Common Stock 299 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes a total of 25 shares purchased under the Issuer's Employee Stock Purchase Plan on September 30, 2024 and December 31, 2024.
F2 Each RSU represents a contingent right to receive one share of Issuer common stock and vested in four annual installments, beginning February 14, 2022.
F3 Each RSU represents a contingent right to receive one share of Issuer common stock and vested in four annual installments, beginning February 14, 2023.
F4 Each RSU represents a contingent right to receive one share of Issuer common stock and vested in four annual installments, beginning February 14, 2024.
F5 Each RSU represents a contingent right to receive one share of Issuer common stock and vested in four annual installments, beginning on February 14, 2025.